Edition:
United Kingdom

Advanced Accelerator Applications SA (AAAP.OQ)

AAAP.OQ on NASDAQ Stock Exchange Global Select Market

81.63USD
9 Feb 2018
Change (% chg)

-- (--)
Prev Close
$81.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
133,189
52-wk High
$82.74
52-wk Low
$34.98

Latest Key Developments (Source: Significant Developments)

FDA Approves New Treatment For Certain Digestive Tract Cancers
Friday, 26 Jan 2018 

Jan 26 (Reuters) - U.S. FDA :FDA APPROVES NEW TREATMENT FOR CERTAIN DIGESTIVE TRACT CANCERS.U.S. FDA SAYS GRANTED APPROVAL OF LUTATHERA TO ADVANCED ACCELERATOR APPLICATIONS.  Full Article

Advanced Accelerator Applications To Withdraw ADSs From Nasdaq Global Select Market​
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Advanced Accelerator Applications Sa ::ADVANCED ACCELERATOR APPLICATIONS SA - ‍NOTIFIED NASDAQ STOCK MARKET OF ITS DETERMINATION TO WITHDRAW ADSS FROM LISTING ON NASDAQ GLOBAL SELECT MARKET​.ADVANCED ACCELERATOR APPLICATIONS SA - ‍ NOTIFIED NASDAQ STOCK MARKET OF ITS DETERMINATION TO WITHDRAW REGISTRATION OF ORDINARY SHARES.ADVANCED ACCELERATOR APPLICATIONS - ‍ INTENDS TO FILE A FORM 25 WITH SEC NO EARLIER THAN 10 DAYS FROM JAN 22, TO EFFECT DELISTING, WITHDRAWAL.ADVANCED ACCELERATOR APPLICATIONS-NOT ARRANGED FOR LISTING OF ADSS ON OTHER NATIONAL SECURITIES EXCHANGE,AND FOR QUOTATION OF ADSS IN QUOTATION MEDIUM​.ADVANCED ACCELERATOR APPLICATIONS-FOLLOWING CLOSING OF OFFER, 5 EXISTING BOARD MEMBERS HAVE RESIGNED AND 4 NEW BOARD MEMBERS HAVE BEEN CO-OPTED​.ADVANCED ACCELERATOR APPLICATIONS- ‍ CLAUDIO COSTAMAGNA HAS RESIGNED FROM HIS OFFICE AS CHAIRMAN, BOARD APPOINTED SUSANNE SCHAFFERT AS NEW CHAIRMAN​.  Full Article

Advanced Accelerator Applications Announces Commencement Of Novartis Tender Offer
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Advanced Accelerator Applications Sa ::ADVANCED ACCELERATOR APPLICATIONS ANNOUNCES COMMENCEMENT OF NOVARTIS TENDER OFFER.ADVANCED ACCELERATOR APPLICATIONS - UNIT OF NOVARTIS COMMENCED CASH TENDER OFFER TO PURCHASE ALL OF CO'S ORDINARY SHARES FOR $41.00/SHARE, $82.00/ADS.ADVANCED ACCELERATOR APPLICATIONS SA - OFFER WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON JANUARY 19, 2018, UNLESS EXTENDED.  Full Article

Advanced Accelerator Applications Board Recommends $3.9 Bln All Cash Tender Offer By Novartis
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Advanced Accelerator Applications Sa ::ADVANCED ACCELERATOR APPLICATIONS BOARD OF DIRECTORS RECOMMENDS $3.9 BILLION ALL CASH TENDER OFFER BY NOVARTIS.ADVANCED ACCELERATOR APPLICATIONS - CO'S BOARD RECOMMENDS $3.9 BILLION ALL CASH TENDER OFFER BY NOVARTIS.  Full Article

Advanced Accelerator Applications reports qtrly loss per share EUR​ ‍0.26
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Advanced Accelerator Applications SA :Advanced Accelerator Applications reports 39% sales growth for third quarter 2017.Q3 sales rose 39 percent to $43.9 million.Advanced Accelerator Applications SA qtrly loss per share EUR​ ‍0.26.  Full Article

Advanced Accelerator Applications reports 24.4% sales growth in Q2
Wednesday, 31 Aug 2016 

Advanced Accelerator Applications Sa : Advanced Accelerator Applications reports 24.4% sales growth in the second quarter of 2016 . Q2 sales rose 24.4 percent to eur 27.64 million .Qtrly loss per share eur 0.02.  Full Article

Advanced Accelerator Applications announces FDA priority review for Lutathera
Monday, 27 Jun 2016 

Advanced Accelerator Applications Sa : Advanced accelerator applications announces FDA priority review for Lutathera . FDA has accepted company's new drug application and granted priority review for Lutathera .Prescription drug user fee act (PDUFA) target action date is December 28, 2016.  Full Article

Cardinal Health to prepare NETSPOT doses for Advanced Accelerator Applications
Thursday, 9 Jun 2016 

:Advanced Accelerator Applications S.A. says selected Cardinal Health to supply Gallium 68 dotatate doses to u.s. Hospitals and imaging centers.  Full Article

Advanced Accelerator Applications gets FDA approval of NetSpot
Thursday, 2 Jun 2016 

Advanced Accelerator Applications : Advanced Accelerator Applications Announces FDA Approval Of Netspot(Tm) (Somakit-tate), a kit for the preparation of Gallium GA 68 Dotatate for neuroendocrine tumor detection .Advanced Accelerator Applications SA says Netspot TM will be made available to US market as soon as possible.  Full Article

Advanced Accelerator Q1 sales rose 29.6 pct to EUR26.92 mln
Tuesday, 31 May 2016 

Advanced Accelerator Applications SA : Advanced accelerator applications reports 29.6 pct sales growth in the first quarter of 2016 .Q1 sales rose 29.6 percent to EUR 26.92 million.  Full Article

LIVE MARKETS-Pharma M&A, a sobering view from Moody's

Feb 12 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net PHARMA M&A, A SOBERING VIEW FROM MOODY'S (1210 GMT) The multiplication of M&A deals in the pharmaceutical sector has sure got some investors excited, equity investors that is, as those focusing on debt might ta